Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of aging-associated disease with modulators of leukotriene A4 hydrolase

Treatment of aging-associated disease with modulators of leukotriene A4 hydrolase

US Patent 11426399 · Granted Aug 30, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and t2025
Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and t2025
Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and t2024
Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and t2024
Dosing regimen for treatment of cognitive and motor impairments with blood plasm2022
Treatment of aging-associated disease with modulators of leukotriene A4 hydrolas2022
Treatment of aging-associated disease with modulators of leukotriene A4 hydrolas2022
Treatment of aging-associated disease with modulators of leukotriene A4 hydrolas2022
Dosing regimen for treatment of cognitive and motor impairments with blood plasm2021
Dosing regimen for treatment of cognitive and motor impairments with blood plasm2021
Dosing regimen for treatment of cognitive and motor impairments with blood plasm2020
Dosing regimen for treatment of cognitive and motor impairments with blood plasm2019